Article 04 Jun 2024 Federal Court Of Appeal Upholds Invalidity Of Lilly's CIALIS Patent Extending To "Physiologically Acceptable Salt" Canada IP
Article 01 Mar 2023 Lilly's CIALIS Patent Claims Extending To "physiologically Acceptable Salt" Found Invalid For Overbreadth And Insufficiency Canada IP
Article 30 May 2022 Supreme Court Of Canada Denies Merck Leave To Appeal From Decision Upholding Strict Interpretation Of Patent Listing Deadline Canada IP
Article 02 Dec 2021 Federal Court Of Appeal Dismisses Appeal, Upholds Strict Interpretation Of Patent Listing Deadline For KEYTRUDA Formulation Patent Canada Healthcare
Article 04 Nov 2021 Supreme Court Of Canada Denies Leave Regarding Lisdexamfetamine Patent Decision Canada IP